ITEM 7.01 REGULATION FD DISCLOSURE
On August 14, 2014, we issued a press release announcing that we had priced our
underwritten public offering of 3,333,333 shares of common stock at a per share
price of $3.75 and warrants to purchase up to the same number of shares of
common stock at a per warrant price of $0.01; plus the issuance of approximately
an additional 1,110,000 shares and warrants in consideration of the cancellation
of $4,000,000 principal amount of convertible debentures plus accrued interest.
Both our common stock and the warrants issued in conjunction with this offering
will be listed on the NASDAQ Capital Market under the symbols "CLRB" and
"CLRBW," respectively. A copy of the press release is furnished as Exhibit 99.1
and is incorporated by reference herein.
ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS
99.1 Press release dated August 14, 2014, entitled "Cellectar
Biosciences Announces Pricing of $12,500,000 Public Offering and
Listing on The Nasdaq Capital Market"